Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Signature Genomic Ink Oligo Microarray Supply Agreement

NEW YORK (GenomeWeb News) – Agilent Technologies will supply microarrays to Signature Genomic Laboratories and its customers under a new long-term agreement, Signature said today.
 
Under the agreement, Agilent will supply Signature and customers using the SignatureChip Oligo Solution with its custom oligonucleotide microarrays, the Spokane, Wash.-based company said.
 
The SignatureChip OS is used in detecting chromosome abnormalities in individuals with mental retardation/developmental delay, autism, and congenital abnormalities.
 
The company said the agreement also allows users of its Genoglyphix software to use the oligo arrays in their research applications.
 
Signature offers its microarray-based cytogenetic diagnostic and chromosome analysis products to clinical geneticists, neurologists, pediatricians, and other physicians and researchers.
 
Financial terms of the agreement were not released.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.